Walgreens Boots Alliance Inc (WBA) Q1 Profit & Revenue Top Expectations

Saturday, 06 Jan, 2018

Other large investors also recently made changes to their positions in the company. Andra AP fonden lifted its holdings in shares of Walgreens Boots Alliance by 35.3% in the second quarter.

Internationally, the retail pharmacy arm of Walgreens Boots Alliance brought in sales of $3.1bn (£2.3bn), an increase of 4.1 per cent year-on-year. Gabelli Funds LLC now owns 403,200 shares of the pharmacy operator's stock valued at $31,135,000 after buying an additional 3,000 shares during the last quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator's stock worth $102,000 after buying an additional 6 shares during the period. Zions Bancorporation boosted its position in shares of Walgreens Boots Alliance by 983.3% in the third quarter. State of Wisconsin Investment Board now owns 1,401,555 shares of the pharmacy operator's stock valued at $108,228,000 after purchasing an additional 68,141 shares during the last quarter. Walgreens attributed the gain mainly to higher prescription volumes, including mail and central specialty pharmacy in the wake of the formation of AllianceRx Walgreens Prime. Walgreens Boots Alliance has a 1-year low of $63.82 and a 1-year high of $88.00. (NASDAQ:WBA) opened at 85.88 on Tuesday. The company has a market cap of $74,780.00, a price-to-earnings ratio of 19.98, a price-to-earnings-growth ratio of 1.30 and a beta of 1.22. Medler was the chief information security officer and director of information technology security of Raytheon Missile Systems, a subsidiary of Raytheon Company, a position she held until December 2017. The stock has a 50 day moving average of $83.68 and a 200 day moving average of $82.71.

Fiscal 2018 first quarter net earnings attributable to Walgreens Boots Alliance determined in accordance with GAAP reduced 22.1 percent to $821 million compared with the same quarter a year ago, while GAAP diluted net earnings per share reduced 16.5 percent to $0.81 compared with the same quarter a year ago. The pharmacy operator reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.21 by $0.10. For those of you who are trading Walgreens Boots Alliance, Inc., the weekly volatility is 1.67% and performance for the week is 3.02%.

Revenues rose 7.9% from a year ago to $30.74 billion, also topping analysts' view for $30.39 billion. The company's revenue was up 5.3% on a year-over-year basis. equities research analysts expect that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

Looking ahead, WAG forecast full-year EPS of $5.45 to $5.70, up slightly from a prior range of $5.40 to $5.70.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 10th. The Weekly Volatility is 1.28% and the Monthly Volatility is 2.24%. Walgreens Boots Alliance's payout ratio is 42.33%.

Several research analysts recently commented on the stock. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a report on Monday, December 4th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a "buy" rating in a research report on Thursday, October 26th. Needham & Company LLC reissued a "buy" rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a report on Sunday, September 10th.

TRADEMARK VIOLATION NOTICE: "Walgreens Boots Alliance (NASDAQ:WBA) Rating Increased to Buy at Zacks Investment Research" was originally reported by StockNewsTimes and is owned by of StockNewsTimes. First Trust Advisors LP increased its holdings in Walgreens Boots Alliance by 79.7% in the 3rd quarter. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company's stock. The stock was sold at an average price of $67.37, for a total value of $184,324.32. 7,145,315 shares of the company's stock traded hands, compared to its average volume of 6,160,000. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

In other news, Director William C. Foote sold 2,736 shares of the business's stock in a transaction dated Thursday, November 2nd. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now directly owns 600 shares of the company's stock, valued at $48,408. The disclosure for this purchase can be found here. The legal version of this news story can be accessed at https://weekherald.com/2018/01/04/private-vista-llc-raises-holdings-in-walgreens-boots-alliance-inc-wba.html.